Table 1 Correlation between LINC00511 expression and clinicopathological characteristics of breast cancer patients
Clinical parameter test p-value | No. cases (n = 70) | LINC00511 expression | Chi-squared | |
---|---|---|---|---|
High cases | Low cases | |||
Age (years) | Â | Â | Â | 0.75 |
≤50 | 39 | 14 | 25 |  |
>50 | 31 | 10 | 21 | Â |
Tumour size (cm) | Â | Â | Â | 0.03 |
≤2 | 33 | 7 | 26 |  |
>2 | 37 | 17 | 20 | Â |
TNM stages | Â | Â | Â | 0.08 |
I–II | 65 | 20 | 45 |  |
III–IV | 5 | 4 | 1 |  |
Histological grade | Â | Â | Â | 0.77 |
I–II | 51 | 18 | 33 |  |
III | 19 | 6 | 13 | Â |
LNM | Â | Â | Â | 0.74 |
Positive | 36 | 13 | 23 | Â |
Negative | 34 | 11 | 23 | Â |
ER status | Â | Â | Â | <0.01 |
Positive | 19 | 1 | 18 | Â |
Negative | 51 | 23 | 28 | Â |
PR status | Â | Â | Â | 0.04 |
Positive | 14 | 1 | 13 | Â |
Negative | 56 | 23 | 33 | Â |
Her2 status | Â | Â | Â | 0.06 |
Positive | 37 | 9 | 28 | Â |
Negative | 33 | 15 | 18 | Â |
Ki-67 status | Â | Â | Â | 0.02 |
≤14% | 54 | 23 | 31 |  |
>14% | 16 | 1 | 15 | Â |
P53 status | Â | Â | Â | <0.01 |
Positive | 29 | 16 | 13 | Â |
Negative | 41 | 8 | 33 | Â |